GLYRX-PF
Generic name:glycopyrrolate
Dosage form: injection, solution
Drug class:Anticholinergics / antispasmodics
Medically reviewed by Drugs.com. Last updated on Jul 22, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Warnings
- Precautions
- Patient Counseling Information
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- How Supplied/Storage and Handling
Indications and Usage for GLYRX-PF
GLYRX®-PF is indicated:
in anesthesia (all ages)
- •
- for reduction of salivary, tracheobronchial, and pharyngeal secretions, reduction of volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anesthesia and intubation,
- •
- intraoperatively to counteract surgically or drug-induced or vagal reflex-associated arrhythmias, and
- •
- for protection against peripheral muscarinic effects of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing agents.
in peptic ulcer (adults)
- •
- as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.
GLYRX-PF Dosage and Administration
General Dosage and Administration Information
- •
- Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
- •
- GLYRX®-PF may be administered intramuscularly or intravenously, with or without dilution.
Dosing in Adults
Preanesthetic Medication
The recommended dose of GLYRX®-PF is 0.004 mg/kg by intramuscular injection, given 30 to 60 minutes prior to the anticipated time of induction of anesthesia or at the time the preanesthetic narcotic and/or sedative are administered.
